Yi Fei Zhu
Corporate Officer/Principal chez I-MAB
Profil
Yi Fei Zhu is currently the Chief Commercial Officer at I-Mab.
Prior to this, he held the position of Vice President & General Manager-Sales Division at Qilu Pharmaceutical Co., Ltd.
and Chief Commercial Officer at BeiGene Ltd.
He also previously worked as Chief Commercial Officer at I-MAB Biopharma Co., Ltd.
Zhu received his undergraduate degree from Zhejiang University in 1992.
Postes actifs de Yi Fei Zhu
| Sociétés | Poste | Début |
|---|---|---|
| I-MAB | Corporate Officer/Principal | 10/08/2020 |
Anciens postes connus de Yi Fei Zhu
| Sociétés | Poste | Fin |
|---|---|---|
| BEIGENE, LTD. | Corporate Officer/Principal | 01/03/2019 |
Qilu Pharmaceutical Co., Ltd.
 Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Sales & Marketing | 01/03/2019 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Sales & Marketing | - |
Formation de Yi Fei Zhu
| Zhejiang University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| I-MAB | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Health Technology |
